Home > International Directory of Company Histories > QLT Inc. - Introduction

1. Printable Version
2. Download PDF
3. Cite this Page
4. Tweet This

Introduction

887 Great Northern Way
Vancouver, British Columbia V5T 4T5
Canada
Telephone: (604) 707-7000
Toll Free: (800) 663-5486
Fax: (604) 707-7001
Web site: http://www.qltinc.com

Public Company
Incorporated: 1981 as Quadra Logic Technologies
Employees: 329
Sales: $186.1 million (2004)
Stock Exchanges: NASDAQ Toronto
Ticker Symbols: QLTI; QLT
NAIC: 325412 Pharmaceutical Preparation Manufacturing

QLT Inc. is a biotechnology company that develops and markets photodynamic therapeutic products—drugs that are activated by exposure to light. The company has a history of developing treatments for cancer, but its greatest commercial success is Visudyne, a light-activated treatment for age-related macular degeneration, the leading cause of blindness in people over age 50. Other pharmaceutical products in the company's development pipeline include treatments for prostate cancer, skin cancer, and male pattern baldness. The acquisition of Atrix Laboratories in 2004 gave QLT a second marketable pharmaceutical product named Eligard, which is a treatment for advanced prostate cancer.

1. Introduction
2. Origins
3. Photofrin in the Mid-1980s
4. The Development of Visudyne in the 1990s
5. Company Perspectives:
6. Commercial Success in the 2000s
7. Principal Subsidiaries
8. Principal Competitors
9. Key Dates:
10. Further Reading
11. Copyright Page
12. About Page